Stock data
Rocket Pharmaceuticals, Inc. (RCKT)
Rocket Pharmaceuticals, Inc. (RCKT) reported revenue of US$0.00M and net income of -US$223.12M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | US$0.00M | — | -US$231.75M | -US$223.12M | — |
| 2024 | US$0.00M | — | -US$273.20M | -US$258.75M | — |
| 2023 | US$0.00M | — | -US$259.66M | -US$245.59M | — |
| 2022 | US$0.00M | — | -US$224.34M | -US$221.86M | — |
| 2021 | US$0.00M | — | -US$167.25M | -US$169.07M | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | US$0.00M | US$123.21M | — |
| 2026-03-31 | US$0.00M | -US$47.59M | — |
| 2025-12-31 | US$0.00M | -US$42.54M | — |
| 2025-09-30 | US$0.00M | -US$50.33M | — |
| 2025-06-30 | US$0.00M | -US$68.92M | — |
| 2025-03-31 | US$0.00M | -US$61.33M | — |
| 2024-12-31 | US$0.00M | -US$60.33M | — |
| 2024-09-30 | US$0.00M | -US$66.72M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.